The US Food and Drug Administration is looking for OTC and Rx drug manufacturers to participate in two quality management maturity (QMM) pilots that would rate and assign scores to facilities as the agency realigns its quality metrics program to emphasize quality management maturity.
As an incentive to participate, companies assigned high scores will be accorded regulatory flexibility. An added benefit is that participants...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?